Barclays upgrades Schott Pharma on growth inflection; shares jump

Barclays has upgraded Schott Pharma, citing a growth inflection point for the company. This positive analyst action has led to a significant jump in Schott Pharma shares. While other stocks including Odfjell Drilling, Sixt, Duos Technologies, and Duolingo are also experiencing rallies, the specific driver for the Schott Pharma increase is the recent upgrade from Barclays. The market is reacting positively to the revised outlook provided by the financial institution regarding the company's growth trajectory.